What does Sichuan Huiyu Pharmaceutical Co., Ltd. do?

Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688553.SS's market cap?

Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) has a market capitalization of approximately $7.52 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 688553.SS pay a dividend?

Yes — Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) pays a dividend annually, with a trailing-twelve-month yield of 1.66%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

688553.SS

Sichuan Huiyu Pharmaceutical Co., Ltd.

SHH·Drug Manufacturers, Specialty & Generic · Healthcare

¥12.02¥0.06+0.50%

Market cap¥7.52B·Aug 26 7:00 AM UTC

Price Chart

¥12.02+¥0.06 (+0.50%)today

−55.08%CAGR −15.26%

Select date range

FromTo

Oct 26, 2021Oct 26, 2021 → Aug 26, 2026· 4.8 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)1.66%

Annual Dividend (FWD)¥0.20

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio284.5%

FCF Payout Ratio88.9%

Most Recent Dividend¥0.200

Ex-Dividend DateJun 17

Payment DateJun 17

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−42.8%

EPS Growth (3Y)−9.9%

EPS Growth (5Y)−26.7%

Next Earnings DateAug 21

Last Report DateAug 21

Reported vs Estimate¥0.06

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.10B

Net Income¥114.17M

Net Margin10.4%

Operating Cash Flow¥217.61M

Capital Expenditures¥76.87M

Free Cash Flow¥140.74M

Return on Equity3.1%

Return on Invested Capital0.4%

Net Cash¥2.00B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688553.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688553.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688553.SS and 80,000+ other tickers.

About Sichuan Huiyu Pharmaceutical Co., Ltd.

Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug products, such as pemetrexed disodium, methrotrexate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. The company also offers moroxydine sodium chloride, fluorouracil, sodium thiosulfate, acetylcysteine…

CEO: Zhao Ding
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHH
Employees: 1,366
Website: www.huiyupharma.com

Peers

Peers Tab

600789.SS

Shandong Lukang Pharmaceutical Co.,Ltd.

Cap

¥7.7B

002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd.

Cap

¥8.5B

300702.SZ

Zhejiang Tianyu Pharmaceutical Co., Ltd.

Cap

¥7.5B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688553.SS

What does Sichuan Huiyu Pharmaceutical Co., Ltd. do?: Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688553.SS's market cap?: Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) has a market capitalization of approximately $7.52 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 688553.SS pay a dividend?: Yes — Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) pays a dividend annually, with a trailing-twelve-month yield of 1.66%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.